Sfoglia per Autore
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
2006-01-01 Armentero, M. -T.; Levandis, G.; Nappi, G.; Bazzini, E.; Blandini, F.
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: New clues from an old model
2007-01-01 Blandini, F.; Levandis, G.; Bazzini, E.; Nappi, G.; Armentero, M. -T.
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
2008-01-01 Levandis, G.; Bazzini, E.; Armentero, M. -T.; Nappi, G.; Blandini, F.
Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease
2008-01-01 Armentero, M. T.; Levandis, G.; Bramanti, P.; Nappi, G.; Blandini, F.
Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine
2008-01-01 Bazzini, E.; Samuele, A.; Granelli, M.; Levandis, G.; Armentero, M. -T.; Nappi, G.; Blandini, F.
Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease
2010-01-01 Ambrosi, G.; Armentero, M. -T.; Levandis, G.; Bramanti, P.; Nappi, G.; Blandini, F.
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat
2010-01-01 Blandini, F.; Cova, L.; Armentero, M. -T.; Zennaro, E.; Levandis, G.; Bossolasco, P.; Calzarossa, C.; Mellone, M.; Giuseppe, B.; Deliliers, G. L.; Polli, E.; Nappi, G.; Silani, V.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
2011-01-01 Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease
2011-01-01 Armentero, M. T.; Sinforiani, E.; Ghezzi, C.; Bazzini, E.; Levandis, G.; Ambrosi, G.; Zangaglia, R.; Pacchetti, C.; Cereda, C.; Cova, E.; Basso, E.; Celi, D.; Martignoni, E.; Nappi, G.; Blandini, F.
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model
2012-01-01 Colucci, Mario; Cervio, Marila; Faniglione, Marisa; De Angelis, S.; Pajoro, M.; Levandis, Giovanna; Tassorelli, Cristina; Blandini, Fabio; Feletti, Fausto; De Giorgio, R.; Dellabianca, Antonio; Tonini, Stefano; Tonini, Marcello
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease
2012-01-01 Bossolasco, P; Cova, L; Levandis, G; Diana, V; Cerri, S; Lambertenghi Deliliers, G; Polli, E; Silani, V; Blandini, F; Armentero, M T
Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: Potential relevance to the pathophysiology of Parkinson's disease
2012-01-01 Melcangi, R. C.; Caruso, D.; Levandis, G.; Abbiati, F.; Armentero, M. -T.; Blandini, F.
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat
2014-01-01 Vegezzi, G.; Al Harraq, Z.; Levandis, G.; Cerri, S.; Blandini, F.; Gnudi, G.; Miduri, F.; Blandizzi, C.; Domenichini, G.; Bertoni, S.; Ballabeni, V.; Barocelli, E.
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease
2014-01-01 Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G. F.; Franco, R.; Lanciego, J. L.; Baqi, Y.; Muller, C. E.; Pinna, A.; Blandini, F.; Armentero, M. T.
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects
2015-01-01 Cerri, S.; Greco, R.; Levandis, G.; Ghezzi, C.; Mangione, A. S.; Fuzzati-Armentero, M. T.; Bonizzi, A.; Avanzini, M. A.; Maccario, R.; Blandini, F.
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease
2015-01-01 Levandis, Giovanna; Balestra, Barbara; Siani, F.; Rizzo, Vittoria; Ghezzi, Cristina; Ambrosi, Giulia; Cerri, Silvia; Bonizzi, Alberto; Vicini, Riccardo; Vairetti, Mariapia; Ferrigno, Andrea; Pastoris, Ornella; Blandini, Fabio
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
2015-01-01 Ambrosi, G.; Ghezzi, C.; Zangaglia, R.; Levandis, G.; Pacchetti, C.; Blandini, F.
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease
2015-01-01 Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
2016-01-01 Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.
Influence of estrogen modulation on glia activation in a murine model of parkinson's disease
2017-01-01 Siani, F.; Greco, R.; Levandis, G.; Ghezzi, C.; Daviddi, F.; Demartini, C.; Vegeto, E.; Fuzzati-Armentero, M. -T.; Blandini, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease | 1-gen-2006 | Armentero, M. -T.; Levandis, G.; Nappi, G.; Bazzini, E.; Blandini, F. | |
| Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: New clues from an old model | 1-gen-2007 | Blandini, F.; Levandis, G.; Bazzini, E.; Nappi, G.; Armentero, M. -T. | |
| Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease | 1-gen-2008 | Levandis, G.; Bazzini, E.; Armentero, M. -T.; Nappi, G.; Blandini, F. | |
| Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease | 1-gen-2008 | Armentero, M. T.; Levandis, G.; Bramanti, P.; Nappi, G.; Blandini, F. | |
| Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine | 1-gen-2008 | Bazzini, E.; Samuele, A.; Granelli, M.; Levandis, G.; Armentero, M. -T.; Nappi, G.; Blandini, F. | |
| Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease | 1-gen-2010 | Ambrosi, G.; Armentero, M. -T.; Levandis, G.; Bramanti, P.; Nappi, G.; Blandini, F. | |
| Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat | 1-gen-2010 | Blandini, F.; Cova, L.; Armentero, M. -T.; Zennaro, E.; Levandis, G.; Bossolasco, P.; Calzarossa, C.; Mellone, M.; Giuseppe, B.; Deliliers, G. L.; Polli, E.; Nappi, G.; Silani, V. | |
| Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease | 1-gen-2011 | Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F. | |
| Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease | 1-gen-2011 | Armentero, M. T.; Sinforiani, E.; Ghezzi, C.; Bazzini, E.; Levandis, G.; Ambrosi, G.; Zangaglia, R.; Pacchetti, C.; Cereda, C.; Cova, E.; Basso, E.; Celi, D.; Martignoni, E.; Nappi, G.; Blandini, F. | |
| Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model | 1-gen-2012 | Colucci, Mario; Cervio, Marila; Faniglione, Marisa; De Angelis, S.; Pajoro, M.; Levandis, Giovanna; Tassorelli, Cristina; Blandini, Fabio; Feletti, Fausto; De Giorgio, R.; Dellabianca, Antonio; Tonini, Stefano; Tonini, Marcello | |
| Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease | 1-gen-2012 | Bossolasco, P; Cova, L; Levandis, G; Diana, V; Cerri, S; Lambertenghi Deliliers, G; Polli, E; Silani, V; Blandini, F; Armentero, M T | |
| Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: Potential relevance to the pathophysiology of Parkinson's disease | 1-gen-2012 | Melcangi, R. C.; Caruso, D.; Levandis, G.; Abbiati, F.; Armentero, M. -T.; Blandini, F. | |
| Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat | 1-gen-2014 | Vegezzi, G.; Al Harraq, Z.; Levandis, G.; Cerri, S.; Blandini, F.; Gnudi, G.; Miduri, F.; Blandizzi, C.; Domenichini, G.; Bertoni, S.; Ballabeni, V.; Barocelli, E. | |
| Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease | 1-gen-2014 | Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G. F.; Franco, R.; Lanciego, J. L.; Baqi, Y.; Muller, C. E.; Pinna, A.; Blandini, F.; Armentero, M. T. | |
| Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects | 1-gen-2015 | Cerri, S.; Greco, R.; Levandis, G.; Ghezzi, C.; Mangione, A. S.; Fuzzati-Armentero, M. T.; Bonizzi, A.; Avanzini, M. A.; Maccario, R.; Blandini, F. | |
| Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease | 1-gen-2015 | Levandis, Giovanna; Balestra, Barbara; Siani, F.; Rizzo, Vittoria; Ghezzi, Cristina; Ambrosi, Giulia; Cerri, Silvia; Bonizzi, Alberto; Vicini, Riccardo; Vairetti, Mariapia; Ferrigno, Andrea; Pastoris, Ornella; Blandini, Fabio | |
| Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells | 1-gen-2015 | Ambrosi, G.; Ghezzi, C.; Zangaglia, R.; Levandis, G.; Pacchetti, C.; Blandini, F. | |
| Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease | 1-gen-2015 | Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A. | |
| Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration | 1-gen-2016 | Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L. | |
| Influence of estrogen modulation on glia activation in a murine model of parkinson's disease | 1-gen-2017 | Siani, F.; Greco, R.; Levandis, G.; Ghezzi, C.; Daviddi, F.; Demartini, C.; Vegeto, E.; Fuzzati-Armentero, M. -T.; Blandini, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile